These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24080690)

  • 61. Favourable changes to the IP and tax systems in the UK for drug development.
    Watson R
    Expert Opin Ther Pat; 2013 Jul; 23(7):773-5. PubMed ID: 23713616
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR
    Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
    [No Abstract]   [Full Text] [Related]  

  • 63. Health policy or intellectual property policy? The fight over Bill C-91. Canadian Healthcare Association.
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 1997; 10(2-3):vii-x. PubMed ID: 10169229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. India remains on US trade "priority watch list" for failing to uphold international drug company patents.
    Arie S
    BMJ; 2013 May; 346():f2949. PubMed ID: 23657189
    [No Abstract]   [Full Text] [Related]  

  • 65. Campaigners urge India to resist pressure to change patent laws.
    Kmietowicz Z
    BMJ; 2015 Jun; 350():h3218. PubMed ID: 26066656
    [No Abstract]   [Full Text] [Related]  

  • 66. Drug patents: innovation v. accessibility.
    Collier R
    CMAJ; 2013 Jun; 185(9):E379-80. PubMed ID: 23630237
    [No Abstract]   [Full Text] [Related]  

  • 67. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India.
    Malhotra P
    Indian J Med Ethics; 2008; 5(2):61-5. PubMed ID: 18624153
    [TBL] [Abstract][Full Text] [Related]  

  • 69. India to consider raft of new compulsory licences.
    Bagcchi S
    BMJ; 2014 Jan; 348():g1094. PubMed ID: 24464388
    [No Abstract]   [Full Text] [Related]  

  • 70. Patents: a threat to innovation?
    Manocaran M
    Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract]   [Full Text] [Related]  

  • 71. Patent litigation in India continues to throw up new challenges.
    Reddy Thikkavarapu P
    Pharm Pat Anal; 2016 Jul; 5(4):211-6. PubMed ID: 27348790
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Balancing access and innovation: India's Supreme Court rules on imatinib.
    Rajkumar R; Kesselheim AS
    JAMA; 2013 Jul; 310(3):263-4. PubMed ID: 23824051
    [No Abstract]   [Full Text] [Related]  

  • 73. The new patent regime and disease priorities in India.
    Gupta I; Guin P; Trivedi M
    Glob Public Health; 2013; 8(1):37-54. PubMed ID: 22845021
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes to India's patent law: unaffordable drugs may discourage diagnosing HIV and increase transmission.
    Joshi SB
    BMJ; 2005 Apr; 330(7498):1025. PubMed ID: 15860836
    [No Abstract]   [Full Text] [Related]  

  • 75. Patentability issues surrounding antivirals.
    Lu DL; Collison AM; Kowalski TJ
    Nat Biotechnol; 2007 Dec; 25(12):1403-4. PubMed ID: 18066035
    [No Abstract]   [Full Text] [Related]  

  • 76. MSF challenges pneumococcal vaccine patent in India.
    Usher AD
    Lancet Infect Dis; 2018 Mar; 18(3):254-255. PubMed ID: 29428402
    [No Abstract]   [Full Text] [Related]  

  • 77. Overview of the Hatch-Waxman Act and its impact on the drug development process.
    Mossinghoff GJ
    Food Drug Law J; 1999; 54(2):187-94. PubMed ID: 11758572
    [No Abstract]   [Full Text] [Related]  

  • 78. International trade and Canadian patent law.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2001; 6(1-2):47-53. PubMed ID: 11837027
    [No Abstract]   [Full Text] [Related]  

  • 79. IP issues facing researchers by Gino D'Oca.
    Almarsson O; Angiolini M; Baell J; Giardina G; Ingham A; Hughes A; Pevarello P; Sindelar R
    Pharm Pat Anal; 2012 May; 1(2):129-35. PubMed ID: 24236778
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New rules for natural products research.
    Gollin MA
    Nat Biotechnol; 1999 Sep; 17(9):921-2. PubMed ID: 10471938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.